Montage Technology Co. has overtaken Contemporary Amperex Technology Co. Ltd. as the most expensive dual-listed stock in Hong Kong relative to its mainland shares, propelled by surging demand for AI chips. Chipmaker Montage jumped 17% in Hong Kong on Wednesday, pushing its shares to a 40% premium over its Shanghai-listed stock, the widest gap among companies trading in both markets. Since its Hong...
Montage Technology Co. has overtaken Contemporary Amperex Technology Co. Ltd. as the most expensive dual-listed stock in Hong Kong relative to its mainland shares, propelled by surging demand for AI chips. Chipmaker Montage jumped 17% in Hong Kong on Wednesday, pushing its shares to a 40% premium over its Shanghai-listed stock, the widest gap among companies trading in both markets. Since its Hong Kong debut in February, Montage’s mainland stock has risen 22% while H-shares have tripled after initially listing at a discount . The gap underscores how strong demand is from global investors seeking semiconductor exposure in the region. Peer Gigadevice Semiconductor Inc. is close behind with a premium of about 35%, as expectations for sustained spending on computing capacity fuel fresh inflows into memory-related stocks. In contrast, CATL’s long-standing lead has faded, with its premium narrowing to 26% after a $5 billion share sale boosted supply. The gap climbed to 49% in March, supported by strong earnings and optimism about energy storage demand. CATL had held the top spot for months.
Russia vows ‘retaliatory’ strikes if Moscow parade if attacked – despite Ukraine offering truce; departing Orbán surrenders Ukrainian cash and gold. What we know on day 1,534 Continue reading...
Russia vows ‘retaliatory’ strikes if Moscow parade if attacked – despite Ukraine offering truce; departing Orbán surrenders Ukrainian cash and gold. What we know on day 1,534 Continue reading...
TrongNguyen/iStock via Getty Images Investment action I upgraded Trane Technologies ( TT ) to a buy rating previously as the stock valuation has gotten cheaper while underlying demand profile has improved. Today, I am reiterating my buy rating as the demand picture has improved again. Q1 showed solid revenue growth, but more importantly, orders in Americas commercial HVAC and Applied accelerated f...
TrongNguyen/iStock via Getty Images Investment action I upgraded Trane Technologies ( TT ) to a buy rating previously as the stock valuation has gotten cheaper while underlying demand profile has improved. Today, I am reiterating my buy rating as the demand picture has improved again. Q1 showed solid revenue growth, but more importantly, orders in Americas commercial HVAC and Applied accelerated further, which gives better visibility to future growth. With residential potentially becoming less of a drag and TT also benefiting from a stronger domestic manufacturing position, I think the setup remains attractive. Q1 2026 Earnings Review For Q1 , TT reported revenue of $4.97 billion, up 6% y/y with core sales growth of 3.3%. By region, Americas generated ~$4 billion of sales and 4% core sales growth; EMEA reported $640 million of sales, but core sales there fell 1%; and Asia Pacific reported $332 million of sales and 3% core sales growth. Margins were more mixed. Gross profit grew, but gross margin fell 100 bps y/y to 34.8%. Similarly, adj. EBIT grew 4.6% y/y, but adj. EBIT margin was down 21 bps y/y to 16%. Both Americas and Asia Pacific saw margin expansion, while EMEA saw major compression, down 263bps y/y. At the consolidated level, net income was up 6%, and adj. EPS came in at $2.63, a 7.6% y/y growth. Bullish takeaways The commercial HVAC story got stronger again. Previously, the key evidence that suggests a strong demand inflection has started was that Americas Commercial HVAC bookings grew >35% and applied orders had grown by ~120%. But in Q1, we saw even greater strength, in that Americas orders accelerated to 29% from ~24% in Q4, with Commercial HVAC up >40% and applied orders up >160%. My take is that this momentum will continue for the foreseeable future as total book-to-bill improved to 1.35x , and applied book-to-bill stayed >1.6x (was ~2x previously). The implication here is simple. Because orders are still growing faster than revenue, it means the recen...
A water-soluble battery binder developed by Hong Kong-based GRST enables battery recycling with less pollution and greater recovery of critical metals, the company's chief strategy officer, Frank Harley, said in an interview at the BloombergNEF Summit New York on April 22, 2026. The firm "is making the first stage of recycling a lot simpler," Harley said. Hong Kong-based GRST is "working with seve...
A water-soluble battery binder developed by Hong Kong-based GRST enables battery recycling with less pollution and greater recovery of critical metals, the company's chief strategy officer, Frank Harley, said in an interview at the BloombergNEF Summit New York on April 22, 2026. The firm "is making the first stage of recycling a lot simpler," Harley said. Hong Kong-based GRST is "working with seven equipment manufacturers in China and the end customers for them are EVs, typically European EVs and consumer electronics," he said. (Source: Bloomberg)
Meta Platforms (NASDAQ: META) reported first-quarter 2026 results last week that, on the surface, looked spectacular. Revenue jumped 33% year over year to $56.3 billion -- an acceleration from the 24% growth the social media giant posted in the fourth quarter of 2025. And reported diluted earnings per share rocketed 62% to $10.44. But the headline earnings figure deserves an asterisk. A large one-...
Meta Platforms (NASDAQ: META) reported first-quarter 2026 results last week that, on the surface, looked spectacular. Revenue jumped 33% year over year to $56.3 billion -- an acceleration from the 24% growth the social media giant posted in the fourth quarter of 2025. And reported diluted earnings per share rocketed 62% to $10.44. But the headline earnings figure deserves an asterisk. A large one-time tax benefit lifted reported profit by billions of dollars, and stripping it out tells a more sober story -- one in which earnings growth is trailing revenue growth meaningfully as Meta keeps escalating its already enormous spending plans. That gap between revenue growth and adjusted earnings growth is worth a closer look. Continue reading
In this episode of Motley Fool Hidden Gems Investing , Motley Fool contributors Travis Hoium, Lou Whiteman, and Jon Quast discuss: To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center . When you're ready to invest, check out this top 10 list of stocks to buy . A full transcript is below. Continue reading
In this episode of Motley Fool Hidden Gems Investing , Motley Fool contributors Travis Hoium, Lou Whiteman, and Jon Quast discuss: To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center . When you're ready to invest, check out this top 10 list of stocks to buy . A full transcript is below. Continue reading
(RTTNews) - The China stock market has moved higher in three straight sessions, collecting more than 80 points or 2 percent along the way. The Shanghai Composite Index now sits just above the 4,160-point plateau and it's got a strong lead again for Thursday.
(RTTNews) - The China stock market has moved higher in three straight sessions, collecting more than 80 points or 2 percent along the way. The Shanghai Composite Index now sits just above the 4,160-point plateau and it's got a strong lead again for Thursday.
A new study from the University of Chile suggests that common artificial sweeteners may trigger biological changes that are passed down to future generations. The research focused on sucralose and stevia, two of the world’s most widely used non-nutritive sweeteners (NNS). The additives could alter gut microbiota, gene expression and metabolism in mice, with some effects persisting in their first- ...
A new study from the University of Chile suggests that common artificial sweeteners may trigger biological changes that are passed down to future generations. The research focused on sucralose and stevia, two of the world’s most widely used non-nutritive sweeteners (NNS). The additives could alter gut microbiota, gene expression and metabolism in mice, with some effects persisting in their first- and second-generation offspring, even in offspring who were never directly exposed to the...